Skip to content
value.today

Guardian Therapeutics, LLC

Total raised
$30 M
2 rounds on record
Latest round
$20 M
Aug 2018
First round on record
Feb 2018
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Guardian Therapeutics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2018$20 MNo. 2$10 to $50 million

Guardian Therapeutics, LLC: Raise no. 2, Aug 2018

Investors in this round

1 investor had bought by the notice of Aug 15, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Christa Badger Schmidt · Executive Officer · Manager
  • Clarke Badger Atwell · Executive Officer · Manager
  • James C. Gilbert, MD · Executive Officer · Executive Officer & Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James C. Gilbert, MD, Manager. Newest notice filed Aug 15, 2018. Read the notice at the SEC.

equitySEC
Feb 2018$10 MNo. 1$10 to $50 million

Guardian Therapeutics, LLC: Raise no. 1, Feb 2018

Investors in this round

1 investor had bought by the notice of Feb 12, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Christa Badger Schmidt · Executive Officer · Manager
  • James C. Gilbert, MD · Executive Officer · Executive Officer and Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James C. Gilbert, MD, Chief Executive Officer. Newest notice filed Feb 12, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Guardian Therapeutics, LLC chose not to state its revenue in its newest notice of a funding round (Aug 2018).

    SEC Form D · Aug 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Guardian Therapeutics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Guardian Therapeutics, LLC
NameRoleNamed in
Christa Badger SchmidtManagerAug 2018
Clarke Badger AtwellManagerAug 2018
James C. Gilbert, MDExecutive Officer & ManagerAug 2018